Sagnik Chatterjee (S Chatterjee)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 8

Top Topics

Cervical Cancer Screening

Polycystic Ovary Syndrome

Decision Making

Top Venues

Pediatric health, medicine and therapeutics

Journal of medical economics

Current medical research and opinion

This page only lists publications with an associated author ORCID identifier.

Publications

Kunal Saxena, Baanie Sawhney, Soham D Yande, Niranjan Kathe, Sagnik Chatterjee
The Burden of Cervical Conization in Privately Insured Young and Mid-Adult Women in the United States. Vaccines 11 (4) (2023)
Kunal Saxena, Baanie Sawhney, Soham D Yande, Niranjan Kathe, Sagnik Chatterjee
The Burden of Cervical Conization in Privately Insured Young and Mid-Adult Women in the United States. Vaccines 11 (4) (2023)
Miguel A Escobar, Neha Agrawal, Sagnik Chatterjee, Swastik Bhattacharya, Jorge Caicedo, Michael Bullano, Bob G Schultz
Impact of switching prophylaxis treatment from factor VIII to emicizumab in hemophilia A patients without inhibitors. Journal of medical economics (2023)
Nathan T Connell, Jorge Caicedo, N Nieto, Sagnik Chatterjee, A Hait, A K Gupta, Michael Bullano, Bob G Schultz
Real-world healthcare costs and resource utilization in patients with von Willebrand disease and angiodysplasia. Expert review of pharmacoeconomics & outcomes research (2023)
Kunal Saxena, Baanie Sawhney, Soham D Yande, Niranjan Kathe, Sagnik Chatterjee
The Burden of Cervical Conization in Privately Insured Young and Mid-Adult Women in the United States. Vaccines 11 (4) (2023)
Kunal Saxena, Baanie Sawhney, Soham D Yande, Niranjan Kathe, Sagnik Chatterjee
The Burden of Cervical Conization in Privately Insured Young and Mid-Adult Women in the United States. Vaccines 11 (4) (2023)
Katharine Batt, Bob G Schultz, Jorge Caicedo, Christopher S Hollenbeak, Neha Agrawal, Sagnik Chatterjee, Michael Bullano
A real-world study comparing pre-post billed annualized bleed rates and total cost of care among non-inhibitor patients with hemophilia A switching from FVIII prophylaxis to emicizumab. Current medical research and opinion 38 (10) (2022)
Xiaoqin Yang, Kaushal Desai, Neha Agrawal, Kirti Mirchandani, Sagnik Chatterjee, Eric Sarpong, Shuvayu Sen
Treatment, Resource Use and Costs Among Pediatric Patients with Neurofibromatosis Type 1 and Plexiform Neurofibromas. Pediatric health, medicine and therapeutics 11 (2020)